Місце та роль фетоплацентарної системи у розвитку синдрому затримки росту плода (стр. 47 )

103. Хадарцев -химические процессы в управлении био­логическими системами / // Вестн. нов. мед. технологий. -1999. – Т. IV, №2. – С. 34–37.

104. Хакимова дефицит железа и профилактика железоде-фицитной анемии у беременных женщин: Метод. рекоменд. / , // – Душанбе, 2011. – 16 с.

105. Чернуха факторов роста в функции репродуктивной системы / , // Пробл. репродукции. – 1996. – №2. – С. 8–12.

106. Чуб дисфункция: основы патогенеза, про­блемы диагностики, тактика лечения: метод рекомендации / , , . – Луганск, 2012. – 43 с.

107. Шаповаленко диагностика и лечение плацентарной недостаточности у беременных на ранних стадиях гестации / ­валенко // Вестн. Рос. ассоц. акуш.-гин. – 2001. – №2. – С.43–47.

108. Шехтман гемодинамики при анемии у беременных / , B. C. Горенбаум, // Акуш. и гин. –1985. – №1. –С. 46–48.

109. Шехтман по экстрагенитальной патологии у бере­менных / // М.: Триада-Х, 2003. – 816 с.

110. Altered mRNA expression pattern of placental epidermal growth factor receptor (EGFR) in pregnancies complicated by preeclampsia and/or in­trauterine growth retardation / [M. Faxen, J. Nastell, A. Blanck et al.] // Am. J. Perinatol. –1998.– Vol.15, №l. – P. 9–13.

111. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta-2-glycoprotein I / [Di Simone N., Meroni P. L. et al.] // Arthritis. Rheum. – 2011. – Vol. 43, №1. – P. 140–150.

112. Antiphospholipids antibodies: pathophysiological aspects and fetal outcome / [C. Yaman, W. Arzt, G. Tulzer, et al.] // Z. Geburtshilfe Neonatol. – 2008. Vol.201, №4. – P. 235–239.

113. Antiplatelet agents for preventing preeclampsia and its compli­cations (Cochrane Review) / [L. Duley, D. J. Henderson-Smart, M. Knight et al.] // Cochrane Library. – Chichester: John Wiley and Sons, 2008. – Vol. 3, №4.- Р. 89-102.

114. Aplin J. D. Anchorage in the developing placenta: an overlooked determi­nant of pregnancy outcome? / [J. D. Aplin, T. Haigh et al.] // Hum. Fertil. (Camb). –2008. Vol.1, N. l. – P. 75–79.

115. Apoptosis and reproduction / [M. Caprio, E. Fabbrini, M. Andrea Isi-dori et al.] // Trends in Endocrinology & Metabolism. – 2011. – Vol.12, №2. – P. 65–72.

116. Arbeille P. Fetal arterial Doppler-IUGR and hypoxia / P. Arbeille // Eur. J. Obstet. Gynecol. Reprod. Biol. – 2007. – Vol. 75, №1. – P. 51–53.

117. Asherson R. A. The Catastrophic Antiphospholipid Syndrome (Asherson’s Syndrome) / R. A. Asherson. – Johannesburg, 2005. – 539 p.

118. Assessment of fetoplacental and uteroplacental blood flow using duplex pulsed ultrasound in complicated pregnancies / [S. Campbell, C. J. Hernandez, T. A. Cochen-Overbeek et al.] // J. Perinat. Med. – 1994. – Vol.12, №5. – P. 262–265.

119. A study of the relationship between placenta growth factor and gestational age, parturition, rupture of membranes and intrauterine infection / [D. E. Seubert, E. Maymon, P. Pacora et al.] // Am J. Obstet .Gynecol. – 2000. – Vol.182, №6. –P. 1633–1637.

120. Athannassiades A. Role of placenta growth factor (PLGF) in human extra-villious trophoblast proliferation, migration and invasiveness / A. Athannassiades, P. K. Lala // Placenta. – 2008. – Vol.19, №7. – P. 465–473.

121. Autocrine-paracrine regulation of human placental growth and invasion by locally active growth factors / [P. K. Lala, J. J. Lysiak ; Ed. M. Kurpisz et al.] // Immunol Hum Reprod. – 2005. – P. 235–249.

122. Barker D. J.P. Mothers, babies and disease in later life / D. J.P. Barker. –London: B. M.J. Publishing Group, 2004.–18 р.

123. Baschat A. A. Pathophysiology of fetal growth restriction: implications for diagnosis and surveillance /A. A. Baschat // Obstet Gynecol Surv. – 2004. – Vol. 59, №8. – P.617–627.

124. Batra A. Ultrasonic variables in the diagnosis of intrauterine growth retardation / A. Batra, H. K. Chellani // Indian. J. Med. Res. – 2000. – Vol.92. –P.399–403.

125. Baumann H. Doppler sonographic evaluation of blood floow velocity and waveforms changes in fetal, uteroplacental and farge maternal vessels in pregnant women / H. Baumann, A. Huch, R. Huch // J. Perinat. Med. – 2009. – Vol.17, №4. – P. 279–287.

126. Baumgarten K. Intrauterin growth retardation / K. Baumgarten // Eur. J. Obstet. Gynecol.- – 2003. –Vol.15. – P.369–373.

127. Becker V. Virus in the placenta. Alternative infection pathways / V. Becker // Pathologe. – 2012. – Vol.13, №3. – P. 152–157.

128. Benirschke K. Pathology of the human placenta / K. Benirschke, P. Kauf­mann. – 3rd ed. – New York : Springer-Verlag, 2005. – 871 p.

129. Berger R. Perinatal brain injury /R. Berger, Y. Gamier // J. Perinat. Med. –2000. –Vol. 28, №4. – P. 261–285.

130. Benson A. H. Antiphospholipid syndrome in pregnancy / A. H. Benson, H. J. Carp // Curr. Opin. Obstet. Gynecol. 2004. – Vol.16, №2. – P. 129–135.

131. Berne R. M. (ed.). Handbook of Physiology. Section 2 / R. M. Berne // Bethesda, Md: American Physiological Society, 1999.- 433р.

132. Bilateral notching of uterine arteries at 12–14 weeks of gestation for prediction of hypertensive disorders of pregnancy / [M. Vainio, E. Kujansuu et al.] // J. Acta Obstet. Gynecol. Scand. – 2005. – Vol.84, № 11. – P. 1062–1067.

133. Biochemical evidence for autocrine/paracrine regulation of apoptosis in cultured uterine epithelial cells during mouse embryo implantation in vitro / [T. Ka­mijo, M. R. Rajabi, H. Mizunuma et al.] // Мої. Hum. Rerod. – 2008. – Vol.4, № 10. – P. 990–998.

134. Bischof P. Molecular mediators of implantation. / P. Bischof, А. Сатрапа // Clin Obstet. Gynaecol. – 2000. – Vol.4, №5. – P. 801–814.

135. Bonney R. C. The endocrinology of implantation and early pregnancy / R. C. Bonney, S. Franks // Baillieres Clin. Endocrinol. Metab. – 1990. – Vol.4, №2. – P. 207–231.

136. Brenner B. Haemostatic changes in pregnancy / B. Brenner // Thromb. Res. – 2004. – Vol.114, №5–6. – P. 409–414.

137. Burgos H. Angiogenic and growth factors in human amniochorion and placenta / H. Burgos // Eur. J. Clin. Invest. – 2003. – Vol.13, №4. – P. 289–296.

138. Campbell S. Growth of the fetal biparietal diameter during normal preg­nancy / S. Campbell, G. B. Newman // The Journal of obstetrics and gynecology of the monwealth. – 1991. – Vol. 78, №6. – P. 513–519.

139. Campbell S. Uterine and fetal Doppler studies in the prediction and assesment of preeclampsia and IUGR / [S. Campbell, K. F. Harrington, S. Bower, et al.] // J. Matern. Fetal. Invest. – 1991. – Vol.1, №2. –P.110.

140. Can unterine artery velocimetiy be a predictor for IUGR and be an indication for ASA treatment? / [M. Uzan, S. Uzan, G. Breart et al.] // Fetal. Diagn. Ther. – 2012. – Vol.7. – P. 1.

141. Carlos T. M. Leukocyte-endothelial adhesion molecules / T. M. Carlos, J. M. Harlan // Blood. – 1994. – Vol.84, №7. – P. 2068–2101.

142. Celermajer D. S. Noninvasive detection of endothelial disfunction in children and adults at risk of atherosclerosis / D. S. Celermajer, K. E. Sorensen, V. M. Gooch // J. Lancet. – 2002. Vol.285. – Р. 1111–1115.

143. Cellular and molecular responses of the uterus to embryo implantation can be elicited by locally applied growth factors / [B. C. Paria, W. Ma, J. Tan et al.] // Proc. Natl. Acad. Sci. U S A. – 2001.– Vol. 98, №3. – P.1047–1052.

144. Cetin I. A multidisciplinary approach to the future of reproduction / I. Cetin, G. Pardi // Placenta. -– 2003. – Vol.1. – P. 3–4.

145. Charnock-Jones D. S. Aspects of human fetoplacental vasculogenesis and angiogenesis. A molecular regulation / D. S. Charnock-Jones, P. Kanfmann, T. M. Mayhew // Placenta. – 2004. – Vol.25, № 2–3. – P. 103–113.

146. Close relationship of endothelial dysfunction in coronary and brachial artery / [A. Uehata, M. D. Gerhard, I. T. Mezerdith et al.] // Circulation. – 2003. – Vol.88. – Р. 611–618.

147.Colocalisation of vascular endothelial growth factor and its Fit— 1 receptor in human placenta / [A. Ahmed, X. F. Li, С Dunk et al.] // Growth Factors. – 2005. – Vol. 12, № 3. – P. 235–243.

plement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome / [G. Girardi, J. Berman, P. Redecha et al.] // J. Clin. Invest. – 2003. – Vol.112, №11. – P. 1644–1654.

149. Concentrations of plasminogen activators and their inhibitors in blood precon­ceptionally, during and after pregnancy / [ M. Coolman, C. J. de Groot, E. A. Steegers et al.] // Eur. J. Obstet. Gynecol. Reprod. Biol. – 2006. – Vol.128, №1–2. – P. 22–28.

150. Conrad K. P. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats / K. P. Conrad, K. A. Vernier // Am. J. Physiol. – 1999. – Vol.257, №4, Pt. 2. – P. 847–853.

151. Coughlin S. R. Protease-activated receptors in hemostasis, thrombosis and vascular biology / S. R. Coughlin. – J. Thromb. Haemost. – 2005. – Vol.3, №8. – P. 1800–1814.

152. Cytokines activation in placenta is required for antiphospholipid antibody - induced fetal loss / [V. M. Olers, G. Irardi et al.] // J. Exp. Med. –2002. –Vol.195, №2. – P. 211–20.

153. Dalteparin for the prevention of recurrence of placenta-medicated complications of pregnancy in women without thrombophilia: a pilot randomized coutrolled trial / [E. Rey, P. Garnean et al.] // J. Thromb. Haemost. – 2009. – Vol.7, №1. – P. 58–64.

154. Decidual cell-expressed tissue factor in human pregnancy and its involvement in hemostasis and preeclampsia-related angiogenesis / [.J. Lockwood, G. Krikun et al.] // Ann. NJ Acad. Sci. – 2008. – Vol.1127. – P. 67–72.

155. Decidual Haemostasis, Inflammation and Angiogenesis in Preeclampsia / [C. J. Lockwood, S. J. Huang et al.] // Seminars in Thromb. Hemost. – 2011. – Vol.37, №2. – P. 158–163.

156. Differential regulation of macrophage arginine metabolism: a proposed role in wound healing / J. D. Shearer, J. R. Richards, CD. Mills на получение научной степени et al.] // Am. J. Physiol. – 1997. –Vol.272, №2, Pt. 1. – P. El 81–190.